Advertisement

Topics

Companies Related to "Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma" [Most Relevant Company Matches] - Page: 20 RSS

10:59 EDT 22nd March 2019 | BioPortfolio

Here are the most relevant search results for "Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma" found in our extensive corporate database of over 50,000 company records.

Showing "Monoclonal Antibody Therapy Vaccine Therapy Treating Patients With" Companies 476–500 of 5,500+

Relevant

AlivaMab Discovery Services, LLC

AlivaMab Discovery Services uses the AlivaMab™ Mouse platform, a patented next generation transgenic mouse platform, to discover human therapeutic antibody candidates for projects conducted on behalf of partners. Chosen by many leading pharmaceutical companies, this best-in-class transgenic platform generates therapeutic antibody candidates with high ...


Mediware Information Systems Inc.

Since 1980, Mediware has provided software solutions to healthcare providers and has since expanded to serve many state and federal agencies. Mediware’s solutions are perfect for high-growth, complex patient care environments that remain underserved by existing vendors. The company employs more than 650 subject matter experts who deeply understand bus...

Rockland Immunochemicals

Rockland Immunochemicals is a global biotechnology company manufacturing leading edge research tools and cGMP grade proteins for basic, applied and clinical research in functional genomics, gene therapy and drug discovery markets. Rockland operates outside of Philadelphia, Pennsylvania, USA. European and Asian markets are supported through a highly specialized network of key distributors. Technolo...


Lotus Tissue Repair, Inc.

Lotus Tissue Repair, Inc. is developing its proprietary recombinant collagen type VII (rC7) technology as a treatment for dermatologic conditions in which rC7 may play an important role in accelerating chronic wound healing, such as diabetic foot ulcers, venous stasis ulcers and similar conditions. The company’s lead program is the first and only prot...

GENOVAC GmbH

The commitment and expertise of our people and our award winning technology has established GENOVAC as a world leader in the rapid generation of polyclonal and monoclonal antibodies through genetic immunization. Innovative proprietary methods enable us to produce highly specific, high-affinity antibodies based on the cDNA sequence alone. This will allow a rapid translation of the wealth of genomic...

Audentes Therapeutics, Inc.

AudentesTM is a biotechnology company committed to the development and commercialization of innovative new treatments for people with serious, rare muscle diseases through the application of adeno-associated virus (AAV) gene therapy technology. The company consists of a focused, experienced and passionate team driven by the goal of improving the lives of p...

MedAutonomic

MedAutonomic is a privately held medtech company dedicated to developing a bioelectric medicine to treat patients with functional diseases of the metabolic syndrome such as type-2 diabetes, hypertension and gastroesophageal reflux disease (GERD). MedAutonomic’s approach is to offer a nonsurgical alternative treatment of functional diseases with a lowe...

Tinnitus Treatment Solutions

Tinnitus Treatment Solutions is an independent professional organization comprised of audiologists specializing in tinnitus counseling and education services. We facilitate screening and treatment of tinnitus patients and offer superior patient-centered care using a sound therapy based approach delivered via modern tele-audiology tools. Visit us online at ...

The Antibody Resource Page

Your Complete guide to antibody research and suppliers

Therachon AG

Therachon is a clinical-stage global biotechnology company focused on developing medicines for rare diseases with significant unmet need. The company’s lead pipeline candidate, TA-46, is a novel protein therapy in development for achondroplasia, the most common form of short-limbed dwarfism. Therachon is committed to translating the promise of its sci...

Ortho Biotech, L.P.

Ortho Biotech Products, L.P. is a leading biopharmaceutical company devoted to helping improve the lives of patients with cancer and with anemia due to multiple causes, including chronic kidney disease. Since it was founded in 1990, Ortho Biotech and its worldwide affiliates have earned a global reputation for researching, manufacturing and marketing innovative products that enhance patients'...

IntraPace, Inc.

IntraPace was founded in 2001 to address an unmet need in weight loss surgery by developing a gentler solution for weight loss that incorporates essential components of behavior therapy. The abiliti system is intended to enable patients to achieve and sustain significant weight loss without the complications, lifestyle restrictions and substantial anatomic...

Immune Pharmaceuticals, Inc.

Immune Pharmaceuticals is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Our lead program, bertilimumab, is a first-in-class, fully human monoclonal antibody that targets and lowers levels of eotaxin-1, a chemokine that plays a role in immune responses and attracts eosinophils to ...

GENOVO Incorporated

Gene therapy using viral vectors for the treatment of cancer, anemia, hepatitis and diabetes.

Selective Genetics

Site specific gene therapy for soft and hard tissue repair and regeneration.

Ventus Medical, Inc.

Ventus Medical is a medical device company focused on improving the lives of patients with sleep-disordered breathing. Located in Belmont, California, Ventus Medical has developed and markets PROVENT Therapy, an innovative, clinically-proven treatment for OSA. Existing OSA solutions do not always meet patients' needs. Through truly innovative technology, solid clinical evidence, and a focus on ...

Crinetics Pharmaceuticals

Crinetics Pharmaceuticals discovers and develops novel therapeutics targeting peptide hormone receptors for the treatment of specialty endocrine disorders in neuroendocrinology, reproductive medicine, and women’s health. Its pioneering small molecule somatostatin agonist program for the treatment of acromegaly and neuroendocrine tumors aims to provide...

Good Biotech Corp.

Good Biotech Corp. (GBC), an unprecedented duck IgY(?Fc) antibody manufacturer based in Taiwan, has successfully built up the technology platform by using duck eggs as bio-reactor to produce Polyclonal IgY (?Fc) Antibody .GBC is the only company with the capability to rapidly mass production duck IgY(?Fc) antibody on an industrial scale, and moreover, to successfully commercialize it in terms of t...

Apexian Pharmaceuticals

Apexian Pharmaceuticals is a clinical-stage biotechnology company focused on developing safe and effective therapy for patients with high unmet medical needs. Apexian’s lead drug candidate APX3330, is an oral first-in-class novel inhibitor of the APE1 protein, a critical node in cancer cell signaling. To learn more about Apexian Pharmaceuticals, pleas...

Intersect ENT, Inc.

Intersect ENT Inc., located in Palo Alto, Calif., is an innovator in local drug delivery focused on advancing clinically proven therapy solutions that improve quality of life for ear, nose and throat patients. The company’s initial focus is a dissolvable steroid-releasing implant to treat patients with chronic sinusitis, a common condition that affect...

Synergy Health Concepts

The team at Pacific Interventionalists launched Synergy Health Concepts to focus specifically on CCSVI treatment and care. Chronic Cerebro-Spinal Venous Insufficiency (CCSVI) is characterized by veins that are not adequately able to carry blood from the brain and central nervous system to the heart. Synergy performs various procedures to help relieve CCSVI...

Numab

Founded in 2011, Numab discovers and develops innovative antibody-based therapeutics. Applying proprietary rabbit-based antibody discovery and engineering technology, Numab generates highly potent and stable antibody Fv fragments, which serve as building blocks to create mono- or bi-specific antibody fragment-based therapeutics with tailored pharmacokineti...

Pevion Biotech AG

Pevion Biotech AG is a fully independent Swiss vaccine company that develops innovative vaccines for unmet medical needs based on its clinically and commercially validated virosome technology. Its proprietary clinical pipeline includes a first-in-class candidiasis vaccine. A clinical stage malaria vaccine candidate has been successfully out-licensed, and the Company’s technology has been o...

ProEthic Pharmaceuticals, Inc.

ProEthic is a specialty pharmaceutical company focused primarily in the areas of cardiology, pain and migraine. Founded in 2001, the privately held company focuses its efforts on the acquisition, development, licensing, and marketing of pharmaceutical products. Its lead product, Lipofen(R), is indicated as adjunctive therapy to diet to reduce elevated triglycerides and to increase HDL-C in adu...

BioGenes - Gesellschaft für Biopolymere mbH

BioGenes is a world-wide acting full-service supplier of protein analysis services, customised polyclonal and monoclonal antibodies as well as immunoassays with strong commitment to quality and service. BioGenes supports customers with a whole range of GMP-compliant analytical services starting from feasibility assessments to complete immunoassay development, validation, manufacturing, and impleme...


More From BioPortfolio on "Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks